Two-Sample Mendelian Randomization Study of Lipid levels and Ischemic Heart Disease

Abstract

Background and Objectives Associations between blood lipids and risk of ischemic heart disease (IHD) have been reported in observational studies. However, due to confounding and reverse causation, observational studies are influenced by bias, thus their results show inconsistency in the effects of lipid levels on IHD. In this study, we evaluate whether lipid levels have an effect on the risk of IHD in a Korean population. Methods A 2-sample Mendelian randomization (MR) study, using the genetic variants associated with lipid levels as the instrumental variables was performed. Genetic variants significantly associated with lipid concentrations were obtained from the Korean Genome and Epidemiology Study (n=35,000), and the same variants on IHD were obtained from the Korean Cancer Prevention Study-II (n=13,855). Inverse variance weighting (IVW), weighted median, and MR-Egger approaches were used to assess the causal association between lipid levels and IHD. Radial MR methods were applied to remove outliers subject to pleiotropic bias. Results Causal association between low-density lipoprotein-cholesterol (LDL-C) and IHD was observed in the IVW method (odds ratio, 1.013; 95% confidence interval, 1.007–1.109). However, high-density lipoprotein-cholesterol (HDL-C) and triglyceride (TG) did not show causal association with IHD. In the Radial MR analysis of the relationship between HDL-C, TG and IHD, outliers were detected. Interestingly, after removing the outliers, a causal association between TG and IHD was found. Conclusions High levels LDL-C and TG were causally associated with increased IHD risk in a Korean population, these results are potentially useful as evidence of a significant causal relationship.

Genetic Variants Associated with Adverse Events after Angiotensin-Converting Enzyme Inhibitor Use: Replication after GWAS-Based Discovery

“…With the introduction of new genetic techniques, many studies have found novel genetic variants in the field of cardiology. 9 Recently, genome-wide association studies (GWASs) have reported several genetic variants associated with AEs: for example, a study by the PREDICTION-ADR consortium on patients of European descent reported AE-associated single-nucleotide polymorphisms (SNPs) in a few novel genes, including GABRG2 . 10 In addition, several significant SNPs were identified in studies with different designs, such as GWAS discovery, replication, and meta-analysis.…”

Efficacy and Safety of Fenofibrate-Statin Combination Therapy in Patients With Inadequately Controlled Triglyceride Levels Despite Previous Statin Monotherapy: A Multicenter, Randomized, Double-blind, Phase IV Study

“…25 These differences could be the reason that hypertriglyceridemia is an independent risk factor of cardiovascular disease in the Asian population. 26 , 27 Therefore, management of lipid levels, including TG, is particularly important in those of Asian ethnicity, 28 and fenofibrate-statin combination therapy could be an effective strategy to achieve this treatment goal.…”

Managing of Dyslipidaemia Characterized by Accumulation of Triglyceride-Rich Lipoproteins

“…The current strong interest in strategies to lower triglycerides in plasma is largely driven by the concept that this may attenuate atherosclerosis on top of cholesterol-lowering drugs. The support for this idea is provided by genetic studies that have recently suggested a causal link between increased levels of triglycerides and the risk of atherosclerotic cardiovascular disease (ASCVD) [2][3][4][5][6].…”